CHAI and partners, including United Kingdom’s Department for International Development (DFID), Unitaid, MedAccess (backed by the UK government), the United States President’s Emergency Plan for AIDS Relief (PEPFAR), the African Society for Laboratory Medicine (ASLM), and the government of Zambia, reach a breakthrough pricing agreement with Hologic to significantly lower the cost of state-of-the art diagnostic testing for HIV, hepatitis, and cervical cancer in low-and middle-income countries at a price of US$12 per patient sample.